Repertoire inks autoimmune deal with Genentech as it eyes a return to the clinic

Every few years, Repertoire Immune Medicines makes a major announcement in April. And this year is no different. The Flagship Pioneering-incubated startup on Wednesday unveiled a tie-up with Roche's Genentech centered on developing a treatment ...